Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients

Mario Roselli; Patrizia Ferroni; Ilaria Portarena; Silvia Riondino; Francesca La Farina; Vincenzo Formica; Matteo Vergati; Fiorella Guadagni

doi:10.1160/TH12-06-0418

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2012; 108(06): 1243-1245
DOI: 10.1160/TH12-06-0418

Letters to the Editor

Schattauer GmbH

Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients

Mario Roselli^*

¹Medical Oncology, Department of Internal Medicine, Tor Vergata Clinical Center, University of Rome “Tor Vergata”, Rome, Italy

,

Patrizia Ferroni^*

²Department of of Advanced Biotechnologies and Bioimaging, IRCCS San Raffaele Pisana, Rome, Italy

,

Ilaria Portarena

¹Medical Oncology, Department of Internal Medicine, Tor Vergata Clinical Center, University of Rome “Tor Vergata”, Rome, Italy

,

Silvia Riondino

²Department of of Advanced Biotechnologies and Bioimaging, IRCCS San Raffaele Pisana, Rome, Italy

,

Francesca La Farina

²Department of of Advanced Biotechnologies and Bioimaging, IRCCS San Raffaele Pisana, Rome, Italy

,

Vincenzo Formica

¹Medical Oncology, Department of Internal Medicine, Tor Vergata Clinical Center, University of Rome “Tor Vergata”, Rome, Italy

,

Matteo Vergati

¹Medical Oncology, Department of Internal Medicine, Tor Vergata Clinical Center, University of Rome “Tor Vergata”, Rome, Italy

,

Fiorella Guadagni

²Department of of Advanced Biotechnologies and Bioimaging, IRCCS San Raffaele Pisana, Rome, Italy

References
1 Blann AD, Dunmore S. Arterial and venous thrombosis in cancer patients. Cardiol Res Pract 2011; 2011: 394740.
2 Di Nisio M, Ferrante N, De Tursi M. et al. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemost 2010; 104: 1049-1054.
3 Liebman HA, Khorana AA, Kessler CM. Clinical Roundtable Monograph: The Oncologist’s Role in the Management of Venous Thromboembolism. Clin Adv Hematol Oncol 2011; 9: 1-15.
4 Guyatt GH, Akl EA, Crowther M. et al. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th Edition). Chest 2012; 141: 7S-47S.
5 Agterof MJ, van Bladel ER, Schutgens RE. et al. Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration. Thromb Haemost 2009; 102: 683-687.
6 Ay C, Dunkler D, Marosi C. et al. Prediction of venous thromboembolism in cancer patients. Blood 2010; 116: 5377-5382.
7 Douma RA, van Sluis GL, Kamphuisen PW. et al. Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients. Explanations and potential ameliorations. Thromb Haemost 2010; 104: 831-836.
8 Legnani C, Cini M, Scarvelis D. et al. Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil®D-dimer HS 500, in patients with clinically suspected venous thromboembolism. Thromb Res 2010; 125: 398-401.
9 Ferroni P, Martini F, Portarena I. et al. Novel High-Sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in lung cancer patients. Clin Lung Cancer, epub ahead of print. 2012